Kenvue Inc. $KVUE Shares Bought by HF Advisory Group LLC

HF Advisory Group LLC raised its holdings in Kenvue Inc. (NYSE:KVUE) by 68.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 262,948 shares of the company’s stock after buying an additional 107,005 shares during the quarter. HF Advisory Group LLC’s holdings in Kenvue were worth $4,536,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. J.W. Cole Advisors Inc. raised its position in shares of Kenvue by 3.8% in the 2nd quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock valued at $324,000 after purchasing an additional 574 shares during the last quarter. Mackenzie Financial Corp increased its stake in Kenvue by 18.4% during the 2nd quarter. Mackenzie Financial Corp now owns 267,392 shares of the company’s stock valued at $5,597,000 after purchasing an additional 41,554 shares in the last quarter. Lido Advisors LLC increased its stake in Kenvue by 217.4% during the 2nd quarter. Lido Advisors LLC now owns 76,142 shares of the company’s stock valued at $1,594,000 after purchasing an additional 52,150 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of Kenvue in the second quarter worth $3,033,000. Finally, Arrowstreet Capital Limited Partnership purchased a new position in shares of Kenvue in the second quarter worth $6,528,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

KVUE has been the topic of a number of research analyst reports. Citigroup boosted their price objective on shares of Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a report on Wednesday, February 18th. UBS Group raised their target price on Kenvue from $17.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Canaccord Genuity Group lifted their price target on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and cut their price objective for the company from $23.00 to $18.00 in a report on Friday, January 30th. Finally, Argus upgraded Kenvue to a “hold” rating in a research note on Friday, March 6th. Three research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $19.58.

Kenvue Stock Up 0.8%

Shares of KVUE stock opened at $17.39 on Thursday. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The stock has a market cap of $33.32 billion, a P/E ratio of 22.58, a P/E/G ratio of 3.91 and a beta of 0.61. The stock has a 50 day moving average of $18.01 and a 200 day moving average of $17.10. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.22 by $0.05. The business had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.26 EPS. As a group, sell-side analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.8%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is currently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.